Targeting MUC15 Protein in Cancer: Molecular Mechanisms and Therapeutic Perspectives

Author(s): Simei Zhang, Wunai Zhang, Ying Xiao, Tao Qin, Yangyang Yue, Weikun Qian, Xin Shen, Qingyong Ma, Zheng Wang*

Journal Name: Current Cancer Drug Targets

Volume 20 , Issue 9 , 2020

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

MUC15, a member of the mucin family, is a heavily glycosylated transmembrane protein with the primary functions of lubricating surfaces, establishing a selective molecular barrier at the epithelium and mediating signal transduction. Aberrant expression of MUC15 plays a crucial role in the progression of multiple diseases, including malignant tumors. MUC15 has been identified as a tumor suppressor, but current evidence indicate its function as an oncogene in different types of cancers. MUC15 has been shown to be involved in the development of cancer and influence cellular growth, adhesion, invasion, metastasis and immune immunomodulation. However, the precise role of MUC15 in tumour development has not been thoroughly clarified. Here, we systematically summarize the structure and function of MUC15 in cancer, and discuss its potential role in cancer treatment.

Keywords: MUC15, cancer proliferation, metastasis, tumour therapy, glycosylated transmembrane protein, signal transduction.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 9
Year: 2020
Published on: 28 September, 2020
Page: [647 - 653]
Pages: 7
DOI: 10.2174/1568009620666200601140639
Price: $65

Article Metrics

PDF: 15